Sun Tanning Alternatives

The Food and Drug Administration gave the green light to a phase 1/2 trial of KSQ-001EX for patients with melanoma, head and neck squamous cell carcinoma and non-small cell lung cancer.

In this episode of the “CURE Talks Cancer” podcast, we spoke with someone who has undergone 41 surgeries and physically debilitating treatments during his more than 15-year journey with several cases of skin cancer. We discussed his cancer journey, and why, as he starts a new treatment after his most prior therapy failed, he’s focused on quality rather than quantity of life.

CURE® spoke with the director of oncology pharmacy at Massachusetts General Hospital about recent cancer drug shortages that have been making headlines.

In this episode of the “CURE Talks Cancer” podcast, we spoke with Dr. Jeremy Brauer, on behalf of the Skin Cancer Foundation, about current treatment strategies and the future of the disease.

Up to a quarter of patients with breast cancer face financial burden due to the cost of supplements, complimentary therapy and alternative medicines which “may decrease adherence to prescribed medications,” researchers found.

The FDA approved Opdivo for the treatment of patients aged 12 years and older with stage 2B or 2C melanoma that has been surgically removed